Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

VEGFR

Items 1-10 of 54

Page
per page
  1. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  2. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  3. Sorafenib
    A3009 Sorafenib
     11 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  4. VEGFR Tyrosine Kinase Inhibitor II
    C4603 VEGFR Tyrosine Kinase Inhibitor II
     1 Citation
    Summary: VEGFR inhibitor
      ≤25 mg/mL
  5. AAL-993
    C3730 AAL-993
    Summary: VEGF receptors inhibitor
      ≥50.9 mg/mL
  6. Tivozanib (hydrate)
    C3415 Tivozanib (hydrate)
    Summary: VEGFR inhibitor, orally available
      ≤25 mg/mL
  7. MAZ51
    C3342 MAZ51
    Target: VEGFR
    Summary: VEGFR3 antagonist
      insoluble in EtOH; insoluble in H2O; ≥31.4 mg/mL
  8. BAW2881 (NVP-BAW2881)
    B7800 BAW2881 (NVP-BAW2881)
    Summary: VEGFR inhibitor
      ≥42.4 mg/mL
  9. SU 4312
    B6746 SU 4312
    Summary: VEGFR and PDGFR tyrosine kinases inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.45 mg/mL
  10. BFH772
    B6199 BFH772
    Summary: VEGFR2 inhibitor
      ≥53.4 mg/mL

Items 1-10 of 54

Page
per page